Changes after sterile inflammation caused by trabectedin infusion from central venous port: A case report

Trabectedin is an antineoplastic drug used to treat soft tissue sarcomas. Trabectedin is mainly infused from the central venous port (CVP) because trabectedin leakage causes serious skin and soft tissue complications. Characteristic sterile inflammation has recently been reported after infusion of t...

Full description

Bibliographic Details
Main Authors: Jun Kamohara, MD, Takatoshi Kubo, MD, PhD, Koichiro Yasaka, MD, PhD, Hiroshi Kobayashi, MD, PhD, Osamu Abe, MD, PhD
Format: Article
Language:English
Published: Elsevier 2024-10-01
Series:Radiology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1930043324006332